z-logo
Premium
Micrometer‐scale oxygen delivery rearranges cells and prevents necrosis in tumor tissue in vitro
Author(s) -
Toley Bhushan J.,
Park Jaehyun,
Kim ByoungJin,
Venkatasubramanian Raja,
Maharbiz Michel M.,
Forbes Neil S.
Publication year - 2012
Publication title -
biotechnology progress
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 129
eISSN - 1520-6033
pISSN - 8756-7938
DOI - 10.1002/btpr.1510
Subject(s) - oxygen , programmed cell death , biophysics , chemistry , necrosis , cancer cell , reactive oxygen species , in vitro , cell , microbiology and biotechnology , biology , apoptosis , cancer , biochemistry , genetics , organic chemistry
Oxygen availability plays a critical role in cancer progression and is correlated with poor prognosis. Despite this connection, the independent effects of oxygen gradients on tumor tissues have not been measured. To address this, we developed an oxygen delivery device that uses microelectrodes to generate oxygen directly underneath three‐dimensional tumor cylindroids composed of colon carcinoma cells. The extent of cell death was measured using fluorescence staining. Supplying oxygen for 60 h eliminated the necrotic region typically found in the center of cylindroids despite the continued presence of other nutrient gradients. A mathematical model of cylindroid growth showed that the rate of cell death was more sensitive to oxygen than the growth rate. After oxygenation, a ring of dead cells was observed at the outside edge of cylindroids, and dead cells were observed moving outward from cylindroid centers. This movement suggests that dead cells were pushed by viable cells migrating in response to oxygen gradients, a mechanism that may connect transient oxygen gradients to metastasis formation. These measurements show that oxygen gradients are a primary factor governing cell viability and rearrange cells in tumors. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here